Aspire Biopharma Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accountant Fees and Services
The following is a summary of fees paid or to be paid to Bush & Associates CPA, LLC (“Bush”) and Turner, Stone and Company LLP (Turner) for services rendered.
Audit Fees. During the year ended December 31, 2025, fees for our previous independent registered public accounting firm Bush were approximately $101,113 for the services Bush performed in connection with the audit of our December 31, 2024 financial statement included in this Annual Report on Form 10K.
During the year ended December 31, 2025, fees for our current independent registered public accounting firm Turner were approximately $60,250 for the services Turner performed in connection with the audit of our December 31, 2025 financial statement included in this Annual Report on Form 10K.
Audit-Related Fees. During the year ended December 31, 2025, our previous and current independent registered public accounting firm did not render services in connection with any audit-related services.
During the year ended December 31, 2024, our previous and current independent registered public accounting firm did not render services in connection with any audit-related services.
Tax Fees. During the year ended December 31, 2025 and 2024, our previous and current independent registered public accounting firm did not render services to us for tax compliance, tax advice and tax planning.
During the year ended December 31, 2025 and 2024, our previous and current independent registered public accounting firm did not render services to us for tax compliance, tax advice and tax planning.
All Other Fees. During the year ended December 31, 2025 and 2024, there were no fees billed for products and services provided by Bush or Turner other than those set forth above.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.